News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Chelsea Therapeutics, Inc. To Buy Rights To Synergia Pharma, Inc. Drug



5/9/2006 12:02:01 PM

LOS ANGELES, May 8 (Reuters) - Chelsea Therapeutics said on Monday it plans to acquire all rights previously belonging to Synergia Pharma for Droxidopa, a synthetic amino acid used in Japan to treat a type of hypotension associated with Parkinson's Disease and other disorders.


Read at Reuters


comments powered by Disqus
Reuters
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES